glp 1 and dpp4 Differences between GLP-1 receptor agonists DPP-4 inhibitors Cardiovascular effects of the DPP-4

Glucagon like peptide-1 receptor agonists represent a novel class of anti-hyperglycemic agents that have a cardiac-friendly profile, preserve neuronal cells and inhibit neuronal degeneration, an anti-inflammatory effect in liver protecting it against steatosis, increase insulin sensitivity, promote weight loss, and increase satiety or anorexia

A typical cycle structure is 8 to 12 weeks of daily use followed by 4 weeks off

It can lead to a variety of uncomfortable symptoms, including: Nausea Vomiting Feeling full after just a few bites Abdominal bloating or pain Poor appetite Heartburn Feeling full for a long time after eating These symptoms can range from mild to severe, and in some cases, they can significantly disrupt daily life

The frequency of B12 shots varies depending on individual needs and the purpose of usage

Recovery is not linear

282 , E107E116 (2002)